Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04219670 · ClinicalTrials.gov registry record

Inpatient Stroke Recovery Using Sensors

A clinical trial of Stroke, sponsored by Shirley Ryan AbilityLab.

Recruiting
Registry status
400
Enrollment target
1
Study location

NCT04219670: Recruiting study of Stroke, sponsored by Shirley Ryan AbilityLab.

NCT04219670 is a study of Stroke that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 400 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04219670, a study of Stroke, is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.

RECRUITING
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

This observational trial seeks to assess the feasibility of using non-invasive, portable, real-time body-worn sensors to continuously monitor, quantify, and interpret recovery during inpatient treatment of stroke

Primary Outcome

Error between clinical scores estimated from machine learning algorithms trained on sensor data from the Admission time-point, and true scores assessed at the discharge from the hospital.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Wearable sensors

Study Locations (1)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2017-10-31
Est. Completion 2026-12
Shirley Ryan AbilityLab

138 total trials

What NCT04219670 shows while recruiting

NCT04219670 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Wearable sensors is the first listed.

NCT04219670 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04219670 about?

NCT04219670 is a clinical study titled "Inpatient Stroke Recovery Using Sensors". This observational trial seeks to assess the feasibility of using non-invasive, portable, real-time body-worn sensors to continuously monitor, quantify, and interpret recovery during inpatient treatment of stroke

What is the current status of trial NCT04219670?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2017-10-31. Estimated completion is 2026-12.

What conditions does trial NCT04219670 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT04219670?

The interventions under investigation include: Wearable sensors (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04219670?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04219670 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04219670's enrollment target sits among peer trials

400 65th of 454 higher than 388 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04219670, the US trial registry maintained by the National Library of Medicine. NCT04219670 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.